Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation

Biol Blood Marrow Transplant. 2006 Jul;12(7):789-91. doi: 10.1016/j.bbmt.2006.03.008.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Benzamides
  • Bronchiolitis Obliterans / drug therapy*
  • Bronchiolitis Obliterans / etiology
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Piperazines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate